EANM guidance document: dosimetry for first-in-human studies and early phase clinical trials
European Journal of Nuclear Medicine and Molecular Imaging · 2024
DOI: 10.1007/s00259-024-06640-x ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Nuclear Medicine and Molecular Imaging, 2024. Verfasst von Caroline Stokke und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Diagnostic Physics and Computational Radiology, Division of Radiology and Nuclear Medicine, Oslo University Hospital, Oslo, Norway. car…. Hauptthemen laut MEDLINE: Nuclear Medicine, Radiopharmaceuticals. Die Arbeit wurde bisher 56-mal zitiert (Crossref) und nennt 130 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Oslo.
Abstract (Originalsprache)
The numbers of diagnostic and therapeutic nuclear medicine agents under investigation are rapidly increasing. Both novel emitters and novel carrier molecules require careful selection of measurement procedures. This document provides guidance relevant to dosimetry for first-in human and early phase clinical trials of such novel agents. The guideline includes a short introduction to different emitters and carrier molecules, followed by recommendations on the methods for activity measurement, pharmacokinetic analyses, as well as absorbed dose calculations and uncertainty analyses. The optimal use of preclinical information and studies involving diagnostic analogues is discussed. Good practice reporting is emphasised, and relevant dosimetry parameters and method descriptions to be included are listed. Three examples of first-in-human dosimetry studies, both for diagnostic tracers and radionuclide therapies, are given.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Diagnostic Physics and Computational Radiology, Division of Radiology and Nuclear Medicine, Oslo University Hospital, Oslo, Norway. carsto@ous-hf.no.
- Department of Physics, University of Oslo, Oslo, Norway. carsto@ous-hf.no.
- Institute of Radiation Physics, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
- Department of Nuclear Medicine, University Hospital Würzburg, Würzburg, Germany.
- Nuclear Medicine Unit, Department of Experimental and Clinical Medicine, "Magna Graecia" University of Catanzaro, Catanzaro, Italy.
- Department of Clinical Physiology and Nuclear Medicine, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark.
ORCID-Profile: Caroline Stokke, Johannes Tran-Gia, Francesco Cicone, Søren Holm, Thomas Wendler, Nic Gillings, Felix M Mottaghy
Förderung
- University of Oslo
Zitieren
APA
Stokke, C., Gnesin, S., Tran-Gia, J., Cicone, F., Holm, S., Cremonesi, M., Blakkisrud, J., Wendler, T., Gillings, N., Herrmann, K., Mottaghy, F. M., & Gear, J. (2024). EANM guidance document: dosimetry for first-in-human studies and early phase clinical trials. European Journal of Nuclear Medicine and Molecular Imaging. https://doi.org/10.1007/s00259-024-06640-x
Vancouver
Stokke C, Gnesin S, Tran-Gia J, Cicone F, Holm S, Cremonesi M, et al. EANM guidance document: dosimetry for first-in-human studies and early phase clinical trials. European Journal of Nuclear Medicine and Molecular Imaging. 2024. doi:10.1007/s00259-024-06640-x
BibTeX
@article{Stokke2024,
author = {Stokke, Caroline and Gnesin, Silvano and Tran-Gia, Johannes and Cicone, Francesco and Holm, Søren and Cremonesi, Marta and Blakkisrud, Johan and Wendler, Thomas and Gillings, Nic and Herrmann, Ken and Mottaghy, Felix M and Gear, Jonathan},
title = {EANM guidance document: dosimetry for first-in-human studies and early phase clinical trials},
journal = {European Journal of Nuclear Medicine and Molecular Imaging},
year = {2024},
doi = {10.1007/s00259-024-06640-x}
}
EUVIMED